Restasis Eye Drops 0.05% (Cyclosporine) (Single Use)
Cyclosporine 0.5mg
Solution · Prescription medication
AbbVie Korea Co., Ltd.
MFDS item code 200510968 · Approved 2005.06.02 · Insurance code 624900531
Improves tear production suppressed by ocular inflammation associated with dry eye disease
This medication helps improve eye inflammation associated with dry keratoconjunctivitis by increasing tear production in patients whose tear production is suppressed.
Instill 1 drop of this medicine into each eye twice daily, approximately 12 hours apart. Before use, turn the bottle upside down and mix it so that the contents form a uniform, opaque white suspension. If this medicine is used at the same time as artificial tears, administer them 15 minutes apart. Discard any remaining liquid and the container after use.
This medication should be used with caution in patients with a history of herpes simplex keratitis as sufficient studies have not been conducted. Since tear production may not increase, patients using topical anti-inflammatory agents or punctal plugs may experience different effects. Patients with active eye infections or hypersensitivity to any component of this medication should not use it. The most common side effects include a burning sensation in the eye, conjunctival injection, discharge, eye pain, foreign body sensation, itching, and visual disturbances. Rarely, serious hypersensitivity reactions such as eye swelling, angioedema, facial swelling, tongue swelling, pharyngeal swelling, and difficulty breathing may occur, so any abnormal symptoms should be reported to a healthcare professional immediately. Care should be taken to avoid the tip of the container coming into contact with the eye or other surfaces, and because temporary blurred vision may occur after application, it is advisable to avoid driving or operating hazardous machinery. Its safety during pregnancy has not been sufficiently established; therefore, it should be used cautiously only when necessary, and breastfeeding women should also exercise caution. The safety and efficacy of this medication have not been established in children under 16 years of age, and its use is not recommended. After opening, use immediately and discard any remaining solution; make sure the tip does not touch the eye or any other surface to prevent contamination. Do not use this medication while wearing contact lenses; remove lenses before application and they can be reinserted at least 15 minutes after administration. Store this medication out of the reach of children and discard any expired medication. While some animals have shown a tendency to develop cancer with systemic administration, the local dosage of this medication is very low, and its impact on humans is expected to be minimal. This medication is known to have a low risk of genotoxicity or infertility, but it is important to consult a professional immediately if any abnormal reactions or suspected symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is best to maintain the storage temperature between 15 degrees and 25 degrees, which helps to safely preserve the medication's efficacy.
A white opaque or slightly translucent homogeneous liquid in a white translucent container.
0.4mL/tube × 30
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Cyclosporine 0.5mg
Solution · Prescription medication
AbbVie Korea Co., Ltd.

Cyclosporine 25mg
Soft capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Cyclosporine 100mg
Soft capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cyclosporine 250mg
Injections · Prescription medication
Jongkundang Co., Ltd.
Cyclosporine 250mg
Injections · Prescription medication
Novartis Korea Co., Ltd.

Cyclosporine 25mg
Soft capsule · Prescription medication
Novartis Korea Ltd.

Cyclosporine 100mg
Soft capsule · Prescription medication
Novartis Korea Ltd.
Cyclosporine 10g
Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.